GAAP Financial Statements
bioAffinity Technologies, Inc. (BIAFW)
3 quarters · 1 annual periods · CIK 0001712762
Quarterly (3)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Q3 FY2025 | 10-Q | $1.4M | — | -$2.3M | -$5.1M | $-4.74 | $-4.74 | $11.5M | $7.7M |
| Q2 FY2025 | 10-Q | $1.3M | — | -$440.7K | -$4.1M | $-0.17 | $-0.17 | $4.8M | $802.8K |
| Q1 FY2025 | 10-Q | $263.8K | — | -$2.6M | -$2.7M | $-0.16 | $-0.16 | $5.5M | $444.7K |
Annual (1)
| Period | Form | Revenue | Gross Profit | Op. Income | Net Income | EPS (Basic) | EPS (Dil.) | Assets | Cash |
|---|---|---|---|---|---|---|---|---|---|
| FY FY2024 | 10-K | $8.2M | — | -$9.9M | -$9.0M | $-0.75 | $-0.75 | $6.5M | $1.1M |
Source: SEC EDGAR XBRL filings. Per-period figures are pulled from the original 10-Q / 10-K / 20-F submissions. Balance-sheet items (Assets, Cash, Equity) are point-in-time at period end.